Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Anthony A O'Kane"'
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1876:188557
Pancreatic cancer remains an extremely deadly disease, with little improvement seen in treatment or outcomes over the last 40 years. Targeted monoclonal antibody therapy is one area that has been explored in attempts to tackle this disease. This revi
Publikováno v:
Chemical Research in Toxicology. 27:178-187
Despite considerable advances in reducing the production of dioxin-like toxicants in recent years, contamination of the food chain still occasionally occurs resulting in huge losses to the agri-food sector and risk to human health through exposure. D
Publikováno v:
Journal of AOAC INTERNATIONAL. 95:329-334
At the “Standards Development and International Harmonization: AOAC INTERNATIONAL Mid-Year Meeting” on June 29, 2011, an Expert Review Panel (ERP) agreed to further examine AOAC Official MethodSM 2011.01, “Determination of Vitamin B12 by Surfac
Autor:
Pathik Vyas, Anthony A O'Kane
Publikováno v:
Journal of AOAC INTERNATIONAL. 94:1217-1226
A collaborative study was conducted on an inhibition-based protein-binding assay using the Biacore Q™ biosensor instrument and the Biacore Qflex™ Kit Vitamin B12 PI. The samples studied included infant formula, cereals, premixes, vitamin tablets
Autor:
Anthony A O'Kane, Lennart Wahlström
Publikováno v:
Fortified Foods with Vitamins: Analytical Concepts to Assure Better and Safer Products
Autor:
Simon A. Haughey, G. Andrew Baxter, Anthony A O'Kane, Gaylene A. Watene, Marie-José Trisconi, Andras Kalman, Harvey E. Indyk
Publikováno v:
Journal of AOAC INTERNATIONAL. 88:1008-1014
An optical biosensor inhibition immunoassay was developed using a specific pantothenic acid-binding protein for the quantitation of free pantothenic acid (vitamin B5) in foodstuffs. Samples were prepared by a simple extraction procedure in buffer, an
Autor:
Olivier P. Chevallier, Mark Mooney, Christopher T. Elliott, Stewart F. Graham, Anthony A O'Kane
Publikováno v:
Environmental sciencetechnology. 47(10)
Dioxin contamination of the food chain typically occurs when cocktails of combustion residues or polychlorinated biphenyl (PCB) containing oils become incorporated into animal feed. These highly toxic compounds are bioaccumulative with small amounts
Autor:
Hayder Dyer, Tracy Robson, Christopher T. Elliott, Hayley D. McKeen, Lynn McCallum, Anita Yakkundi, Anthony A O'Kane, Lana McClements, Jenny Worthington, David G. Hirst, Helen O. McCarthy
Publikováno v:
Yakkundi, A, McCallum, L, O'Kane, A, Dyer, H, Worthington, J, McKeen, H D, McClements, L, Elliott, C, McCarthy, H O, Hirst, D G & Robson, T 2013, ' The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal Pathway ', PLoS ONE, vol. 8, no. 2, e55075 . https://doi.org/10.1371/journal.pone.0055075
PLoS ONE, Vol 8, Iss 2, p e55075 (2013)
PLoS ONE
PLoS ONE, Vol 8, Iss 2, p e55075 (2013)
PLoS ONE
FK506 binding protein-like (FKBPL) and its peptide derivatives exert potent anti-angiogenic activity in vitro and in vivo and control tumour growth in xenograft models, when administered exogenously. However, the role of endogenous FKBPL in angiogene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82ce156855fc1ba76b44675dd1b1c94a
https://pure.qub.ac.uk/en/publications/08dc9fb7-b055-4035-980c-f3abaca3e4ea
https://pure.qub.ac.uk/en/publications/08dc9fb7-b055-4035-980c-f3abaca3e4ea
Autor:
Vázquez R; Preclinical Department, Early Drug Development Group (E2DG), Boulogne-Billancourt, France.; Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia (IIT), Milan, Italy., Riveiro ME; Preclinical Department, Early Drug Development Group (E2DG), Boulogne-Billancourt, France., Berenguer-Daizé C; Aix Marseille University, CNRS, INP, Institute of NeuroPhysiopathology, Marseille, France., O'Kane A; Discovery and Scientific Affairs Department, Fusion Antibodies plc., Belfast, United Kingdom., Gormley J; Discovery and Scientific Affairs Department, Fusion Antibodies plc., Belfast, United Kingdom., Touzelet O; Discovery and Scientific Affairs Department, Fusion Antibodies plc., Belfast, United Kingdom., Rezai K; Department of Radio-Pharmacology, Institute Curie-René Huguenin Hospital, Saint-Cloud, France., Bekradda M; Preclinical Department, Early Drug Development Group (E2DG), Boulogne-Billancourt, France., Ouafik L; Aix Marseille University, CNRS, INP, Institute of NeuroPhysiopathology, Marseille, France.; APHM, CHU Nord, Service de Transfert d'Oncologie Biologique, Marseille, France.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Jan 06; Vol. 10, pp. 589218. Date of Electronic Publication: 2021 Jan 06 (Print Publication: 2020).
Autor:
Greenfield RS; C-Term Diagnostics Ltd, Southampton, Hants, UK., Herd TM; C-Term Diagnostics Ltd, Southampton, Hants, UK., Date K; Joint Centre for Cancer Studies, Hull York Medical School, Castle Hill Hospital, Cottingham, UK., Cooper P; Department of Coagulation, Royal Hallamshire Hospital, Sheffield, UK., O'Kane A; Fusion Antibodies Ltd, Belfast, N. Ireland., Gardiner E; Joint Centre for Cancer Studies, Hull York Medical School, Castle Hill Hospital, Cottingham, UK., Maraveyas A; Joint Centre for Cancer Studies, Hull York Medical School, Castle Hill Hospital, Cottingham, UK. Electronic address: anthony.maraveyas@hey.nhs.uk.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2019 Apr; Vol. 17 (2), pp. e247-e257. Date of Electronic Publication: 2018 Nov 17.